Private Advisor Group, LLC Inovio Pharmaceuticals, Inc. Transaction History

Private Advisor Group, LLC

  • $17.4 Billion
  • Q4 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022
BUY
$1.44 - $3.98 $14,706 - $40,647
10,213 New
10,213 $18,000
Q2 2021

Aug 12, 2021
SELL
$6.23 - $10.03 $71,987 - $115,896
-11,555 Closed
0 $0
Q1 2021

Apr 22, 2021
SELL
$8.81 - $16.96 $22,218 - $42,773
-2,522 Reduced 17.92%
11,555 $107,000
Q4 2020

Apr 01, 2021
BUY
$8.5 - $12.85 $272 - $411
32 Added 0.23%
14,077 $125,000
Q3 2020

Nov 02, 2020
BUY
$9.57 - $27.05 $8,622 - $24,372
901 Added 6.85%
14,045 $163,000
Q2 2020

Aug 17, 2020
BUY
$7.14 - $31.69 $93,848 - $416,533
13,144 New
13,144 $354,000

Others Institutions Holding INO

# of Institutions
10
Shares Held
281K
Call Options Held
0
Put Options Held
0
View Full List

About INOVIO PHARMACEUTICALS, INC.

INO Quotes by TradingView
  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $486M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email